NCT05900908 2025-04-10
PATHWAyS
GT Medical Technologies, Inc.
Phase 4 Withdrawn
Clinical Trials
6 trialsNCT05728372 2023-10-10
64Cu-DOTA Pembrolizumab for Imaging Metastatic Solid Tumors in Patients Receiving Stereotactic Body Radiation
City of Hope Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT02567643 2022-01-11
Stereotactic Radiosurgery (SRS) for Multiple CNS Mets
The Cooper Health System
Phase NA Withdrawn
NCT03029416 2018-10-15
Two Radiation Dose Schedules of SBRT to Lung Metastases < 5cm in Dimension
University of Kentucky
Phase 2 Withdrawn
NCT01169129 2014-02-04
Surgery and Whole Brain Radiotherapy (RT) Versus Whole Brain Radiotherapy (RT) and Radiosurgery for 1-3 Resectable Brain Metastases
Barretos Cancer Hospital
Phase 3 Withdrawn
NCT00738335 2012-10-04
Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain Metastases
University of California, San Francisco
Phase 1 Withdrawn